Citi Downgrades MacroGenics (MGNX) to Sell

February 4, 2019 4:07 AM

Citi analyst Yigal Nochomovitz downgraded MacroGenics (NASDAQ: MGNX) from Neutral to Sell with a price target of $10.00 (from $22.00).

For an analyst ratings summary and ratings history on MacroGenics click here. For more ratings news on MacroGenics click here.